Journal articles on the topic 'Apolipoprotien C III'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Apolipoprotien C III.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Puchois, P., C. Luley, and P. Alaupovic. "Comparison of four procedures for separating apolipoprotein A- and apolipoprotein B-containing lipoproteins in plasma." Clinical Chemistry 33, no. 9 (September 1, 1987): 1597–602. http://dx.doi.org/10.1093/clinchem/33.9.1597.
Full textMärz, W., G. Schenk, and W. Gross. "Apolipoproteins C-II and C-III in serum quantified by zone immunoelectrophoresis." Clinical Chemistry 33, no. 5 (May 1, 1987): 664–69. http://dx.doi.org/10.1093/clinchem/33.5.664.
Full textVisvikis, S., M. F. Dumon, J. Steinmetz, T. Manabe, M. M. Galteau, M. Clerc, and G. Siest. "Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis." Clinical Chemistry 33, no. 1 (January 1, 1987): 120–22. http://dx.doi.org/10.1093/clinchem/33.1.120.
Full textHata, M., T. Ito, and K. Ohwada. "Kinetic analysis of apolipoproteins in postprandial hypertriglyceridaemia rabbits." Laboratory Animals 43, no. 2 (April 2009): 174–81. http://dx.doi.org/10.1258/la.2008.007004.
Full textMiller, Michael. "Apolipoprotein C-III." Arteriosclerosis, Thrombosis, and Vascular Biology 37, no. 6 (June 2017): 1013–14. http://dx.doi.org/10.1161/atvbaha.117.309493.
Full textHuff, Murray W., and Robert A. Hegele. "Apolipoprotein C-III." Circulation Research 112, no. 11 (May 24, 2013): 1405–8. http://dx.doi.org/10.1161/circresaha.113.301464.
Full textKohan, Alison B. "Apolipoprotein C-III." Current Opinion in Endocrinology & Diabetes and Obesity 22, no. 2 (April 2015): 119–25. http://dx.doi.org/10.1097/med.0000000000000136.
Full textWang, Wenyu, Piers Blackett, Sohail Khan, and Elisa Lee. "Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee." Journal of Lipids 2017 (2017): 1–7. http://dx.doi.org/10.1155/2017/8236325.
Full textHuet, G., M. C. Dieu, A. Martin, G. Grard, J. M. Bard, P. Fossati, and P. Degand. "Heterozygous hypobetalipoproteinemia with fasting chylomicronemia." Clinical Chemistry 37, no. 2 (February 1, 1991): 296–300. http://dx.doi.org/10.1093/clinchem/37.2.0296.
Full textWang, C. S., W. J. McConathy, H. U. Kloer, and P. Alaupovic. "Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III." Journal of Clinical Investigation 75, no. 2 (February 1, 1985): 384–90. http://dx.doi.org/10.1172/jci111711.
Full textMuhtaseb, Najah Al, Abdul Razak Al Yousuf, and J. S. Bajaj. "Apolipoprotein A-I, A-II, B, C-II, and C-III in Children with Insulin-dependent Diabetes Mellitus." Pediatrics 89, no. 5 (May 1, 1992): 936–41. http://dx.doi.org/10.1542/peds.89.5.936.
Full textBlanchard, Valentin, Damien Garçon, Catherine Jaunet, Kevin Chemello, Stéphanie Billon-Crossouard, Audrey Aguesse, Aya Garfa, et al. "A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins." Journal of Lipid Research 61, no. 7 (May 13, 2020): 1128–39. http://dx.doi.org/10.1194/jlr.d120000835.
Full textParsy, D., V. Clavey, C. Fievet, I. Kora, P. Duriez, and J. C. Fruchart. "Quantification of apolipoprotein C-III in serum by a noncompetitive immunoenzymometric assay." Clinical Chemistry 31, no. 10 (October 1, 1985): 1632–35. http://dx.doi.org/10.1093/clinchem/31.10.1632.
Full textZielińska, A., E. Zielinska, J. Wroński, J. Natorska, A. Paradowska-Gorycka, and P. Głuszko. "AB0083 RELATIONSHIP BETWEEN APOLIPOPROTEIN C-III AND ACTIVATED FACTOR VII-ANTITHROMBIN COMPLEXES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1173.2–1173. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3547.
Full textvon Eckardstein, A., H. Holz, M. Sandkamp, W. Weng, H. Funke, and G. Assmann. "Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia." Journal of Clinical Investigation 87, no. 5 (May 1, 1991): 1724–31. http://dx.doi.org/10.1172/jci115190.
Full textNicolay, Alain, Elise Lombard, Emmanuelle Arlotto, Vincent Saunier, Anne-Marie Lorec-Penet, Denis Lairon, and Henri Portugal. "Evaluation of new apolipoprotein C-II and apolipoprotein C-III automatized immunoturbidimetric kits." Clinical Biochemistry 39, no. 9 (September 2006): 935–41. http://dx.doi.org/10.1016/j.clinbiochem.2006.04.021.
Full textDallinga-Thie, G. M., X. D. Bu, M. van Linde-Sibenius Trip, J. I. Rotter, A. J. Lusis, and T. W. de Bruin. "Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III." Journal of Lipid Research 37, no. 1 (January 1996): 136–47. http://dx.doi.org/10.1016/s0022-2275(20)37642-2.
Full textTAKAMATSU, Shigeru, Yoko KAWAMURA, Ikuko OSANAI, Kei SATOH, Seitoku MIZUNO, and Bunichiro SHOJI. "Serum Apolipoprotein C-III in Cerebrovascular Disorders." Journal of Japan Atherosclerosis Society 13, no. 4 (1985): 923–29. http://dx.doi.org/10.5551/jat1973.13.4_923.
Full textvan den Broek, Irene, Fred P. H. T. M. Romijn, Jan Nouta, Arnoud van der Laarse, Jan W. Drijfhout, Nico P. M. Smit, Yuri E. M. van der Burgt, and Christa M. Cobbaert. "Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping." Clinical Chemistry 62, no. 1 (January 1, 2016): 188–97. http://dx.doi.org/10.1373/clinchem.2015.246702.
Full textWolska, Anna, Larry Lo, Denis O. Sviridov, Mohsen Pourmousa, Milton Pryor, Soumitra S. Ghosh, Rahul Kakkar, et al. "A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides." Science Translational Medicine 12, no. 528 (January 29, 2020): eaaw7905. http://dx.doi.org/10.1126/scitranslmed.aaw7905.
Full textNorata, Giuseppe Danilo, Sotirios Tsimikas, Angela Pirillo, and Alberico L. Catapano. "Apolipoprotein C-III: From Pathophysiology to Pharmacology." Trends in Pharmacological Sciences 36, no. 10 (October 2015): 675–87. http://dx.doi.org/10.1016/j.tips.2015.07.001.
Full textAroner, Sarah A., Ming Yang, Junlong Li, Jeremy D. Furtado, Frank M. Sacks, Anne Tjønneland, Kim Overvad, Tianxi Cai, and Majken K. Jensen. "Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk." American Journal of Epidemiology 186, no. 6 (August 4, 2017): 736–44. http://dx.doi.org/10.1093/aje/kwx143.
Full textRiesen, Walter F., and Erich Sturzenegger. "Quantitation of Apolipoprotein C-III in Normal and in Hyperlipaemic Serum Samples by Enzyme-Linked Immunosorbent Assay." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 24, no. 1 (January 1987): 66–72. http://dx.doi.org/10.1177/000456328702400110.
Full textSniderman, Allan D., Jean-Charles Hogue, Jean Bergeron, Claude Gagné, and Patrick Couture. "Non-HDL cholesterol and apoB in dyslipidaemia." Clinical Science 114, no. 2 (December 11, 2007): 149–55. http://dx.doi.org/10.1042/cs20070265.
Full textLee, Chih-Kuo, Che-Wei Liao, Shih-Wei Meng, Wei-Kai Wu, Jiun-Yang Chiang, and Ming-Shiang Wu. "Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis." Biomedicines 9, no. 8 (August 9, 2021): 985. http://dx.doi.org/10.3390/biomedicines9080985.
Full textAlexander, Vickie, Trish Novak, Nicholas Viney, John Su, Jennifer Burkey, Walter Singleton, Richard Geary, and Isis Pharmaceuticals. "AN ANTISENSE INHIBITOR OF APOLIPOPROTEIN C-III LOWERS FASTING PLASMA APOLIPOPROTEIN C-III AND TRIGLYCERIDE CONCENTRATIONS IN HEALTHY VOLUNTEERS." Journal of the American College of Cardiology 59, no. 13 (March 2012): E1685. http://dx.doi.org/10.1016/s0735-1097(12)61686-6.
Full textGaudet, Daniel, Veronica J. Alexander, Brisson Diane, Karine Tremblay, JoAnn Flaim, Steve Hughes, Walter Singleton, and Richard S. Geary. "An Antisense Inhibitor of Apolipoprotein C-III Substantially Decreases Fasting Apolipoprotein C-III and Triglyceride Levels in LPL Deficiency." Journal of Clinical Lipidology 8, no. 3 (May 2014): 353–54. http://dx.doi.org/10.1016/j.jacl.2014.02.090.
Full textOoi, Esther M. M., P. Hugh R. Barrett, Dick C. Chan, and Gerald F. Watts. "Apolipoprotein C-III: understanding an emerging cardiovascular risk factor." Clinical Science 114, no. 10 (April 14, 2008): 611–24. http://dx.doi.org/10.1042/cs20070308.
Full textBlackett, Piers R., Robin Germany, Boureima Sambo, and Petar Alaupovic. "Apolipoprotein C-III Bound to Apolipoprotein B-containing Lipoproteins in Obese Girls." Clinical Chemistry 49, no. 2 (February 1, 2003): 303–6. http://dx.doi.org/10.1373/49.2.303.
Full textBeck, L. S., and H. Fromm. "A role for apolipoprotein C-III in hypertriglyceridemia?" Gastroenterology 89, no. 5 (November 1985): 1203–4. http://dx.doi.org/10.1016/0016-5085(85)90232-x.
Full textRamms, Bastian, and Philip L. S. M. Gordts. "Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism." Current Opinion in Lipidology 29, no. 3 (June 2018): 171–79. http://dx.doi.org/10.1097/mol.0000000000000502.
Full textWang, Heng, Felicia Hunter, and Dennis D. Black. "Effect of feeding diets of varying fatty acid composition on apolipoprotein expression in newborn swine." American Journal of Physiology-Gastrointestinal and Liver Physiology 275, no. 4 (October 1, 1998): G645—G651. http://dx.doi.org/10.1152/ajpgi.1998.275.4.g645.
Full textWopereis, Suzan, Stephanie Grünewald, Éva Morava, Johannes M. Penzien, Paz Briones, M. Teresa Garcı́a-Silva, Pierre N. M. Demacker, Karin M. L. C. Huijben, and Ron A. Wevers. "Apolipoprotein C-III Isofocusing in the Diagnosis of Genetic Defects in O-Glycan Biosynthesis." Clinical Chemistry 49, no. 11 (November 1, 2003): 1839–45. http://dx.doi.org/10.1373/clinchem.2003.022541.
Full textAlessandri, Cesare, Stefania Basili, Marina Maurelli, Paola Andreozzi, Anna Colletta, Michele Paradiso, and Corrado Cordova. "Apolipoproteins C-II and C-III in Peripheral Arterial Disease." Angiology 45, no. 2 (February 1994): 131–36. http://dx.doi.org/10.1177/000331979404500208.
Full textHIBINO, Akira, Susumu YUKAWA, Takao MAEDA, Toshihiko MIYAI, Masahiro KINOSHITA, and Hiroshi NOMOTO. "Very Low Density Lipoprotein-triglyceride Hydrolysis by Lipoprotein Lipase and Apolipoprotein C-II/C-III Ratio in Very Low Density Lipoproteins." Journal of Japan Atherosclerosis Society 15, no. 1 (1987): 255–59. http://dx.doi.org/10.5551/jat1973.15.1_255.
Full textBreyer, Emelita D., Ngoc-Anh Le, Xianzhou Li, Deborah Martinson, and W. Virgil Brown. "Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size." Journal of Lipid Research 40, no. 10 (October 1999): 1875–82. http://dx.doi.org/10.1016/s0022-2275(20)34904-x.
Full textMendivil, Carlos O., Chunyu Zheng, Jeremy Furtado, Julian Lel, and Frank M. Sacks. "Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins." Arteriosclerosis, Thrombosis, and Vascular Biology 30, no. 2 (February 2010): 239–45. http://dx.doi.org/10.1161/atvbaha.109.197830.
Full textChan, Dick C., Gerald F. Watts, Minh N. Nguyen, and P. Hugh R. Barrett. "Apolipoproteins C-III and A-V as Predictors of Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B-100 Kinetics." Arteriosclerosis, Thrombosis, and Vascular Biology 26, no. 3 (March 2006): 590–96. http://dx.doi.org/10.1161/01.atv.0000203519.25116.54.
Full textWOO, SANG-KOO, and HYUN-SIK KANG. "Apolipoprotein C-III SstI Genotypes Modulate Exercise-Induced Hypotriglyceridemia." Medicine & Science in Sports & Exercise 36, no. 6 (June 2004): 955–59. http://dx.doi.org/10.1249/01.mss.0000128200.38372.82.
Full textAdiels, Martin, Marja‐Riitta Taskinen, Elias Björnson, Linda Andersson, Niina Matikainen, Sanni Söderlund, Juhani Kahri, et al. "Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia." Diabetes, Obesity and Metabolism 21, no. 8 (August 2019): 1861–70. http://dx.doi.org/10.1111/dom.13744.
Full textSacks, Frank M., Chunyu Zheng, and Jeffrey S. Cohn. "Complexities of plasma apolipoprotein C-III metabolism: Fig. 1." Journal of Lipid Research 52, no. 6 (March 18, 2011): 1067–70. http://dx.doi.org/10.1194/jlr.e015701.
Full textde Messieres, Michel, Rick K. Huang, Yi He, and Jennifer C. Lee. "Amyloid Triangles, Squares, and Loops of Apolipoprotein C-III." Biochemistry 53, no. 20 (May 13, 2014): 3261–63. http://dx.doi.org/10.1021/bi500502d.
Full textAhmad, Tareq Y., John R. Guyton, James T. Sparrow, and Joel D. Morrisett. "Apolipoprotein C-III/sphingomyelin recombinants: formation, isolation, and characterization." Biochemistry 25, no. 15 (July 1986): 4407–14. http://dx.doi.org/10.1021/bi00363a035.
Full textMalmendier, C. L., J. F. Lontie, G. A. Grutman, and C. Delcroix. "Metabolism of apolipoprotein C-III in normolipemic human subjects." Atherosclerosis 69, no. 1 (January 1988): 51–59. http://dx.doi.org/10.1016/0021-9150(88)90288-2.
Full textYao, Zemin, and Yuwei Wang. "Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production." Current Opinion in Lipidology 23, no. 3 (June 2012): 206–12. http://dx.doi.org/10.1097/mol.0b013e328352dc70.
Full textChan, Dick C., Gerald F. Watts, Trevor G. Redgrave, Trevor A. Mori, and P. Hugh R. Barrett. "Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration." Metabolism 51, no. 8 (August 2002): 1041–46. http://dx.doi.org/10.1053/meta.2002.33339.
Full textSchoch, Leonie, Pablo Sutelman, Rosa Suades, Laura Casani, Teresa Padro, Lina Badimon, and Gemma Vilahur. "Hypercholesterolemia-Induced HDL Dysfunction Can Be Reversed: The Impact of Diet and Statin Treatment in a Preclinical Animal Model." International Journal of Molecular Sciences 23, no. 15 (August 2, 2022): 8596. http://dx.doi.org/10.3390/ijms23158596.
Full textOndruskova, Nina, Tomas Honzik, Hana Kolarova, Zuzana Pakanova, Jan Mucha, Jiri Zeman, and Hana Hansikova. "Aberrant apolipoprotein C-III glycosylation in glycogen storage disease type III and IX." Metabolism 82 (May 2018): 135–41. http://dx.doi.org/10.1016/j.metabol.2018.01.004.
Full textAguilar-Recarte, David, Xavier Palomer, and Manuel Vázquez-Carrera. "Uncovering the role of apolipoprotein C-III in insulin resistance." Clínica e Investigación en Arteriosclerosis (English Edition) 33, no. 2 (March 2021): 108–15. http://dx.doi.org/10.1016/j.artere.2021.04.002.
Full textvan Capelleveen, Julian C., Sophie J. Bernelot Moens, Xiaohong Yang, John J. P. Kastelein, Nicholas J. Wareham, Aeilko H. Zwinderman, Erik S. G. Stroes, et al. "Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk." Arteriosclerosis, Thrombosis, and Vascular Biology 37, no. 6 (June 2017): 1206–12. http://dx.doi.org/10.1161/atvbaha.117.309007.
Full text